These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10783010)

  • 21. Uses of DHEA in aging and other disease states.
    Johnson MD; Bebb RA; Sirrs SM
    Ageing Res Rev; 2002 Feb; 1(1):29-41. PubMed ID: 12039447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
    Takahashi H; Nakajima A; Sekihara H
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):261-4. PubMed ID: 15120419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
    Aoki K; Nakajima A; Mukasa K; Osawa E; Mori Y; Sekihara H
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):469-72. PubMed ID: 12943737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroepiandrosterone: antiglucocorticoid action in mice.
    Browne ES; Wright BE; Porter JR; Svec F
    Am J Med Sci; 1992 Jun; 303(6):366-71. PubMed ID: 1351360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being.
    Huppert FA; Van Niekerk JK; Herbert J
    Cochrane Database Syst Rev; 2000; (2):CD000304. PubMed ID: 10796526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.
    Aoki K; Terauchi Y
    Vitam Horm; 2018; 108():355-365. PubMed ID: 30029734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DHEA replacement for postmenopausal women: placebo or panacea?
    Eden JA
    Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis.
    Garcea R; Daino L; Frassetto S; Cozzolino P; Ruggiu ME; Vannini MG; Pascale R; Lenzerini L; Simile MM; Puddu M
    Carcinogenesis; 1988 Jun; 9(6):931-8. PubMed ID: 2897255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator.
    Waxman DJ
    J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent effect of dehydroepiandrosterone, but not of its sulphate ester, on angiogenesis.
    Varet J; Vincent L; Akwa Y; Mirshahi P; Lahary A; Legrand E; Opolon P; Mishal Z; Baulieu EE; Soria J; Soria C; Li H
    Eur J Pharmacol; 2004 Oct; 502(1-2):21-30. PubMed ID: 15464086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychic effects of dehydroepiandrosterone].
    Rigaud AS; Pellerin J
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS43-9. PubMed ID: 11435994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydroepiandrosterone treatment in the aging male--what should the urologist know?
    Saad F; Hoesl CE; Oettel M; Fauteck JD; Römmler A
    Eur Urol; 2005 Nov; 48(5):724-33; discussion 733. PubMed ID: 16137821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DHEA: panacea or snake oil?
    Sirrs SM; Bebb RA
    Can Fam Physician; 1999 Jul; 45():1723-8. PubMed ID: 10424272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.
    Gordon GB; Bush DE; Weisman HF
    J Clin Invest; 1988 Aug; 82(2):712-20. PubMed ID: 2969922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of serum steroid sex hormones and steroidogenic enzymes following intraperitoneal administration of dehydroepiandrosterone (DHEA) in male rats.
    Song L; Tang X; Kong Y; Ma H; Zou S
    Steroids; 2010 Mar; 75(3):213-8. PubMed ID: 19961867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydroepiandrosterone 3 beta-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca(2+)-channel blockers.
    Ram PA; Waxman DJ
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):753-8. PubMed ID: 8053899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydroepiandrosterone and its derivatives: potentially novel anti-proliferative and chemopreventive agents.
    Matsuzaki Y; Honda A
    Curr Pharm Des; 2006; 12(26):3411-21. PubMed ID: 17017935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity.
    Schwartz AG; Pashko LL
    Ageing Res Rev; 2004 Apr; 3(2):171-87. PubMed ID: 15177053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.